Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biomedical Innovation Departament, |
RCV001352802 | SCV001547297 | pathogenic | Epidermolysis bullosa dystrophica | 2021-03-08 | criteria provided, single submitter | research | |
Invitae | RCV001871902 | SCV002245967 | pathogenic | not provided | 2023-02-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1044*) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with COL7A1-related conditions (PMID: 20184583). ClinVar contains an entry for this variant (Variation ID: 1048003). For these reasons, this variant has been classified as Pathogenic. |